Intended for healthcare professionals

  1. Research
  2. Third generation oral...
  3. Third generation oral contraceptives and risk of venous thrombosis: meta-analysis
Papers

Third generation oral contraceptives and risk of venous thrombosis: meta-analysis

BMJ 2001; 323 doi: https://doi.org/10.1136/bmj.323.7305.131 (Published 21 July 2001) Cite this as: BMJ 2001;323:131

Related articles

See more

Cited by...

  • Location-specific risk factors for intracerebral hemorrhage: Systematic review and meta-analysis
  • 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC)
  • Iron-deficiency and estrogen are associated with ischemic stroke by up-regulating transferrin to induce hypercoagulability
  • FSRH Guideline (January 2019, amended October 2023) Combined Hormonal Contraception
  • Combined oral contraceptives and risk of venous thromboembolism: there is higher risk in new generations compared to second generations, but paradoxically not in norgestimate-containing-pills
  • The association of statin use with reduced incidence of venous thromboembolism: a population-based cohort study
  • Combined oral contraceptives increase risk of venous thrombosis according to oestrogen dose and type of progestogen
  • Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis
  • Authors' reply to Costescu and Waddington
  • Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis
  • Risk of venous thromboembolism in oral contraceptive users varies according to progestin type
  • Difference between drospirenone-containing oral contraceptives and other oral contraceptives related to risk of venous thromboembolism
  • Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data
  • Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database
  • Risk Factors for Venous Thromboembolism
  • The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study
  • Contraception in Women with Medical Problems
  • Inherited thrombophilia and stratification of ischaemic stroke risk among users of oral contraceptives
  • Conjugated Equine Estrogen, Esterified Estrogen, Prothrombotic Variants, and the Risk of Venous Thrombosis in Postmenopausal Women
  • Role of Genetic Analyses in Cardiology: Part II: Heritability Estimation for Gene Searching in Multifactorial Diseases
  • Effect of Tamoxifen on Venous Thromboembolic Events in a Breast Cancer Prevention Trial
  • Venous Thrombosis: The Role of Genes, Environment, and Behavior
  • British Thoracic Society guidelines for the management of suspected acute pulmonary embolism
  • Pharmaceutical industry sponsorship and research outcome and quality: systematic review
  • Diane-35 (cyproterone acetate): safety concerns
  • Influence of the third generation pill controversy on prescriptions for oral contraceptives among first time users: population based study
  • Oral contraceptives, venous thromboembolism, and the courts
  • Western medicine: a confidence trick driven by the drug industry?
  • Hormone Replacement Therapy and the Factor V Leiden Mutation
  • Female Hormones and Thrombosis
  • Hypercoagulability: Too Many Tests, Too Much Conflicting Data
  • Third-Generation Oral Contraceptives and VTE: A Reanalysis
  • The third generation pill controversy (""continued"")
Back to top